AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
Condition(s):Duchenne Muscular DystrophyLast Updated:March 5, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Duchenne Muscular DystrophyLast Updated:March 5, 2024Recruiting
Condition(s):Duchenne Muscular Dystrophy (DMD)Last Updated:August 14, 2023Completed
Condition(s):Duchenne Muscular Dystrophy (DMD)Last Updated:August 26, 2022Recruiting
Condition(s):Duchenne Muscular DystrophyLast Updated:January 17, 2024Recruiting
Condition(s):Duchenne Muscular DystrophyLast Updated:April 21, 2023No longer available
Condition(s):Duchenne Muscular DystrophyLast Updated:December 21, 2020Completed
Condition(s):Duchenne Muscular DystrophyLast Updated:May 17, 2021Completed
Condition(s):Duchenne Muscular DystrophyLast Updated:February 17, 2023Completed
Condition(s):Increased Lordosis/Scoliosis; Hyporeflexia; Duchenne Muscular Dystrophy; Red-Green Color Blindness; Lordosis; Scoliosis; Muscular Atrophy; Muscular WeaknessLast Updated:March 24, 2022Completed
Condition(s):Duchenne Muscular DystrophyLast Updated:July 1, 2015Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.